TY - JOUR
T1 - Protein kinase Cε regulates tumor necrosis factor-α-induced stannin gene expression
AU - Reese, Brian E.
AU - Davidson, Collin
AU - Billingsley, Melvin L.
AU - Yun, Jong
PY - 2005/7
Y1 - 2005/7
N2 - Stannin (Snn) is a highly conserved vertebrate protein that has been closely linked to trimethyltin (TMT) toxicity. We have previously demonstrated that Snn is required for TMT-induced cell death. Others have shown that TMT exposure results in tumor necrosis factor-α (TNFα) production and that TNFα treatment induces Snn gene expression in human umbilical vein endothelial cells (HUVECs). In this study, we investigated a signaling mechanism by which Snn gene expression is regulated by TMT and demonstrated that TNFα stimulates Snn gene expression in a protein kinase Cε-dependent manner in HUVECs in response to TMT exposure. Supporting this, we show that TMT-induced toxicity is significantly blocked by pretreatment with an anti-TNFα antibody in HUVECs. Using a quantitative real-time polymerase chain reaction assay, we also show that the level of Snn gene expression is significantly increased in HUVECs in response to either TMT or TNFα-treatment. This TNFα-induced Snn gene expression is blocked when HUVECs were pretreated with bisindolylmaleimide I, an inhibitor of protein kinase C (PKC). In contrast, when HUVECs were treated with phorbol 12-myristate 13-acetate, a PKC activator, we observed a significant increase in Snn gene expression. Using isotypespecific siRNA against PKC, we further show that knockdown of PKCε, but not PKCδ or PKCζ, significantly blocked TNFα-induced Snn gene expression. Together, these results indicate that TNFα-induced, PKCε-dependent Snn expression may be a critical factor in TMT-induced cytotoxicity.
AB - Stannin (Snn) is a highly conserved vertebrate protein that has been closely linked to trimethyltin (TMT) toxicity. We have previously demonstrated that Snn is required for TMT-induced cell death. Others have shown that TMT exposure results in tumor necrosis factor-α (TNFα) production and that TNFα treatment induces Snn gene expression in human umbilical vein endothelial cells (HUVECs). In this study, we investigated a signaling mechanism by which Snn gene expression is regulated by TMT and demonstrated that TNFα stimulates Snn gene expression in a protein kinase Cε-dependent manner in HUVECs in response to TMT exposure. Supporting this, we show that TMT-induced toxicity is significantly blocked by pretreatment with an anti-TNFα antibody in HUVECs. Using a quantitative real-time polymerase chain reaction assay, we also show that the level of Snn gene expression is significantly increased in HUVECs in response to either TMT or TNFα-treatment. This TNFα-induced Snn gene expression is blocked when HUVECs were pretreated with bisindolylmaleimide I, an inhibitor of protein kinase C (PKC). In contrast, when HUVECs were treated with phorbol 12-myristate 13-acetate, a PKC activator, we observed a significant increase in Snn gene expression. Using isotypespecific siRNA against PKC, we further show that knockdown of PKCε, but not PKCδ or PKCζ, significantly blocked TNFα-induced Snn gene expression. Together, these results indicate that TNFα-induced, PKCε-dependent Snn expression may be a critical factor in TMT-induced cytotoxicity.
UR - http://www.scopus.com/inward/record.url?scp=23044506044&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=23044506044&partnerID=8YFLogxK
U2 - 10.1124/jpet.105.084236
DO - 10.1124/jpet.105.084236
M3 - Article
C2 - 15798003
AN - SCOPUS:23044506044
SN - 0022-3565
VL - 314
SP - 61
EP - 69
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 1
ER -